Endometriosis and infertility can feel like an unfair double burden: living with pain or heavy bleeding while also worrying whether IVF will work. The reassuring reality is that many people with endometriosis still achieve healthy pregnancies with IVF, and outcomes can often be improved further when adenomyosis is identified and treated thoughtfully.
At Rao Hospital in Coimbatore, Tamil Nadu, fertility care for endometriosis and adenomyosis focuses on two things at the same time: protecting ovarian reserve and creating the best possible uterine environment for implantation. That balance is where IVF outcomes often change for the better.
How do endometriosis and adenomyosis affect IVF outcomes?
Endometriosis and adenomyosis can affect IVF outcomes in different ways: endometriosis may reduce egg yield in some patients, while adenomyosis is more consistently linked to lower implantation and live birth rates and higher miscarriage risk. When both conditions coexist, adenomyosis often drives much of the negative effect.
Many couples search for endometriosis and ivf success rates and feel discouraged by what they read online. A more accurate approach is to separate embryo factors from uterine factors and then personalise treatment to the disease pattern, age, and ovarian reserve.
Research summaries have reported that adenomyosis is associated with about a 28% reduction in clinical pregnancy likelihood in IVF/ICSI in one meta-analysis, and later reviews have described around a 41% reduction in live birth rate along with increased miscarriage risk. The evidence is not identical in every study, but the pattern is strong enough that adenomyosis deserves targeted attention before embryo transfer.
The coexistence of endometriosis and adenomyosis is also common, reported as high as 65% to 90% in some studies. Rao Hospital’s fertility specialists in Coimbatore routinely check for both conditions so that the IVF plan does not miss a “hidden” uterine factor.
What is the difference between endometriosis and adenomyosis for fertility?
Endometriosis is endometrial-like tissue outside the uterus that can cause inflammation, adhesions, and endometriomas, while adenomyosis is endometrial-like tissue within the uterine muscle that can disrupt implantation and increase miscarriage risk. The distinction matters because IVF challenges often come from different sites.
Endometriosis can affect fertility through pelvic inflammation, altered tubal function, adhesions around the ovaries, and ovarian cysts called endometriomas. Adenomyosis affects the uterine muscle and junctional zone, which can change uterine contractions, local inflammation, and the receptivity of the endometrium during embryo implantation.
This difference is why a patient can have good-quality embryos but still face repeated implantation failure if adenomyosis is untreated or active.
Do endometriosis and infertility always mean lower IVF success rates?
Endometriosis and infertility do not always mean lower IVF success rates, especially in modern IVF/ICSI settings where fertilisation and embryo development can be well supported. Many reviews suggest that endometriosis alone often does not significantly worsen final outcomes, particularly when uterine factors are normal.
Endometriosis can still influence the IVF journey by reducing the number of eggs retrieved or increasing the chance of cycle difficulty in some patients, especially with severe disease or larger endometriomas. However, many patients with endometriosis achieve pregnancy when embryo quality and transfer timing are optimised.
A practical takeaway for couples in Tamil Nadu is this: a diagnosis of endometriosis is not a verdict. Endometriosis Treatment is most effective when it is matched to the patient’s fertility goal, pain symptoms, ovarian reserve, and ultrasound findings.
Can an endometrioma or prior surgery reduce ovarian response during IVF?
Large endometriomas and ovarian surgery can reduce ovarian reserve or reduce response to stimulation, but effects vary widely by cyst size, surgical technique, and baseline AMH and antral follicle count. Fertility planning should protect ovarian tissue while still addressing pain, cyst complications, and access to follicles.
Rao Hospital’s approach prioritises ovarian preservation. Rao Hospital’s fertility team typically discusses the trade-offs clearly, because removing an endometrioma can relieve pain and improve access during egg retrieval, but surgery can also remove healthy ovarian tissue if not done carefully.
When surgery is not urgently needed, IVF planning may proceed with strategies that minimise ovarian risk while addressing inflammation and uterine readiness.
Why do success rates with adenomyosis look lower in many studies?
IVF success rates with adenomyosis look lower in many studies because adenomyosis can impair implantation, increase inflammatory signalling in the uterus, disrupt the uterine junctional zone, and increase miscarriage risk even when embryos are good. Diffuse disease and uterine enlargement tend to show a stronger negative effect than focal disease.
A useful way to think about adenomyosis is that embryo creation and embryo transfer are two different challenges. IVF can often help with embryo creation, but adenomyosis can still interfere at the implantation stage.
In one cohort study reporting first frozen embryo transfer outcomes, live birth rates were 39.3% with endometriosis, 32.1% with adenomyosis, 25.0% with combined disease, and 48.1% in controls. The same cohort reported miscarriage rates of 19.9%, 34.7%, 39.0%, and 17.6% respectively. These figures are not guarantees, but the pattern helps explain why the uterine factor matters.
Patients seeking more context on ivf success rates with adenomyosis can explore Rao Hospital’s fertility care pathways here.
What tests help confirm adenomyosis or endometriosis before IVF?
Adenomyosis and endometriosis evaluation before IVF usually includes a detailed reproductive health consultation, transvaginal ultrasound by an experienced clinician, and selective use of MRI, ovarian reserve testing, and semen analysis. The goal is to confirm the disease pattern and identify any additional factors that could lower success.
A focused pre-IVF workup often includes:
- Transvaginal ultrasound to look for adenomyosis signs, endometriomas, fibroids, and uterine cavity concerns
- AMH and antral follicle count to assess ovarian reserve, especially in age-related fertility decline
- Semen analysis to assess male-factor infertility alongside female-factor conditions
- Selective MRI when ultrasound findings are unclear or adenomyosis mapping will change treatment planning
- Uterine cavity assessment when clinically indicated, because polyps or adhesions can also reduce implantation
Rao Hospital’s reproductive health consultation model also makes space for symptoms that patients sometimes minimise, such as painful periods, painful intercourse, bowel symptoms around menses, heavy bleeding, or persistent pelvic pain.
What treatment choices can improve IVF outcomes in endometriosis and adenomyosis?
Treatment choices that may improve IVF outcomes include individualised suppression protocols for adenomyosis, careful timing of embryo transfer, selective surgery for endometriosis when clearly indicated, and a freeze-all strategy in appropriate cases. Evidence suggests that pre-IVF GnRH agonist suppression for 1 to 6 months can improve outcomes in some patients.
A clear plan usually separates treatment into two tracks: managing pain and disease activity, and maximising implantation conditions.
The table below summarises how Rao Hospital’s fertility specialists often frame the decision-making using published patterns from studies and day-to-day clinical logic.
| Clinical situation | Common IVF challenge | What studies often report | Typical optimisation options discussed in fertility care |
| Endometriosis without adenomyosis | Variable egg yield, retrieval difficulty in severe disease | Final IVF/ICSI outcomes often similar to controls in many reviews | Stimulation individualisation, careful management of endometriomas, selective surgery only when indicated |
| Adenomyosis (especially diffuse) | Implantation difficulty, higher miscarriage risk | Meta-analyses report lower clinical pregnancy and live birth rates and higher miscarriage risk | Pre-transfer suppression protocols, consider freeze-all and FET, monitor uterine size and symptoms |
| Endometriosis plus adenomyosis | Combined ovarian and uterine factors | One first-FET cohort reported lower live birth and higher miscarriage than either condition alone | Treat adenomyosis activity first, protect ovarian reserve, transfer timing optimisation |
When surgery is part of the plan, surgical technique and fertility intent must guide every decision. For carefully selected patients, laparoscopic surgery for endometriosis can reduce pain, address adhesions, and clarify anatomy while aiming to preserve ovarian tissue.
When does a freeze-all and frozen embryo transfer approach make sense?
A freeze-all approach followed by frozen embryo transfer can make sense when adenomyosis activity is suspected, when the uterus needs time after suppression therapy, or when hormonal stimulation symptoms are significant. Frozen embryo transfer timing can allow the uterine environment to be prepared more deliberately than a fresh transfer cycle.
Some patients also ask about supportive nutrition during preparation. Rao Hospital’s counselling team often discusses sleep, stress regulation, and an anti-inflammatory diet for IVF as part of a broader plan, especially when inflammation and painful periods are prominent.
What practical steps can couples take to support IVF alongside medical treatment?
Couples can support IVF by addressing inflammation drivers, optimising metabolic health, treating anaemia from heavy bleeding, improving sperm health, and prioritising mental wellbeing during repeated cycles. These steps do not replace medical treatment, but they can reduce avoidable barriers and improve treatment tolerance.
Rao Hospital’s patient-centred care model often includes these practical steps:
- Track symptoms and bleeding patterns for at least two cycles to support accurate diagnosis discussions.
- Treat iron deficiency and vitamin deficiencies when tests confirm low levels.
- Optimise weight and insulin resistance in PCOS, because metabolic health can affect egg quality and pregnancy risks.
- Improve sperm parameters with targeted lifestyle changes and evidence-based supplements when a clinician advises them.
- Plan work and family support around key IVF milestones to reduce stress load and missed medications.
Rao Hospital also encourages couples to ask for psychological support early rather than only after repeated disappointments. Emotional support is not an “extra” in fertility care; emotional support protects decision-making and relationship health during treatment.
How does Rao Hospital in Coimbatore personalise IVF for endometriosis and adenomyosis?
Rao Hospital personalises IVF for endometriosis and adenomyosis by mapping disease phenotype, protecting ovarian reserve, improving uterine receptivity before transfer, and supporting the couple through counselling, nutrition, and high-risk pregnancy expertise when conception occurs. A single protocol rarely fits every patient with pelvic pain or uterine disease.
Rao Hospital has served families since 1953 and brings more than 45 years of fertility expertise through CARE, the Centre for Assisted Reproduction and Endoscopy. Rao Hospital has also supported more than 30,000 successful infertility treatments since 1985, which helps Rao Hospital’s teams recognise when a small adjustment in timing or pretreatment can matter.
Couples in Tamil Nadu often seek comprehensive gynaecology services alongside fertility care when symptoms include heavy bleeding, pain, fibroids, thyroid issues, or diabetes. Rao Hospital integrates gynaecology, imaging, counselling, nutrition, and high-risk pregnancy support in one care pathway so that fertility treatment does not feel fragmented.
Patients who want to learn more about the clinical leadership behind this approach can read about the expert fertility specialist in Coimbatore, Dr. Damodar R. Rao here in this blog.
What do the key terms in endometriosis, adenomyosis, and IVF mean?
Endometriosis: Endometriosis is a condition in which endometrial-like tissue grows outside the uterus and can cause inflammation, adhesions, pain, and infertility.
Adenomyosis: Adenomyosis is a condition in which endometrial-like tissue grows within the uterine muscle and can affect implantation and miscarriage risk.
Endometrioma: Endometrioma is an ovarian cyst formed from endometriosis that can affect ovarian reserve and complicate egg retrieval.
GnRH agonist suppression: GnRH agonist suppression is a hormone-based pretreatment used to reduce estrogen-driven disease activity before embryo transfer in selected patients.
Frozen embryo transfer (FET): Frozen embryo transfer is an IVF step in which a previously frozen embryo is transferred in a later cycle after the uterine lining is prepared.
Junctional zone: Junctional zone is the inner layer of uterine muscle near the endometrium that can be disrupted in adenomyosis and affect uterine function.
Frequently Asked Questions
Can you get pregnant with stage 4 endometriosis via IVF?
Pregnancy with stage 4 endometriosis via IVF is possible, and many patients conceive when embryo creation and transfer timing are optimised. Stage 4 endometriosis can reduce ovarian response or complicate retrieval, so an individualised plan is essential.
How does adenomyosis affect IVF implantation?
Adenomyosis can affect IVF implantation by altering uterine contractions, increasing local inflammation, and disrupting the junctional zone, which can reduce endometrial receptivity. Studies frequently associate adenomyosis with lower clinical pregnancy and live birth rates and higher miscarriage risk.
Should I have a laparoscopy before IVF?
Laparoscopy before IVF depends on symptoms, ultrasound findings, ovarian reserve, and prior treatment history. Laparoscopy can help selected patients with pain, adhesions, or endometriomas, but unnecessary ovarian surgery can reduce reserve, so decisions should be individualised.
A careful plan can change the IVF story
Endometriosis and adenomyosis can make fertility feel uncertain, but a phenotype-based plan can turn uncertainty into a clear next step. The most important move is to identify whether adenomyosis is present and then sequence treatment so that embryos and the uterine environment are both supported.
If you are ready to take the next step toward parenthood or need expert guidance on endometriosis and infertility, the team at Rao Hospital is here for you. With over 70 years of compassionate care and more than 30,000 successful infertility treatments since 1985, you are in trusted hands. Call Rao Hospital at +91 96299 19191 or visit Rao Hospital to schedule your consultation, or book directly here: Don’t let endometriosis stand in the way of your parenthood dreams. Schedule a consultation with the best fertility specialists in Coimbatore at Rao Hospital today for a personalized fertility roadmap.